BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
14 %
Last period Gross Margin
What is Gross Margin ?
Gross margin is the proportion of revenue that a company retains after the costs incurred to produce marketable goods and services. The value of 40% is the benchmark for Eyestock Rating calculation.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Gross margin is the proportion of revenue that a company retains after the costs incurred to produce marketable goods and services. The value of 40% is the benchmark for Eyestock Rating calculation.
BioNexus Gene`s Gross Margin for the last twelve months ended 2023-09-30 is 14 %
